NASDAQ:APRE   Aprea Therapeutics, Inc.
Only way I would want to play this stock is if it broke over the $8.4 resistance area and proved that it could have a gap fill potential (likely would not actually fill this gap but should be able to run a bit more). What I’m not loving about this ticker is the news was ultra fluffy AND there’s a lot of resistance. Of course that doesn’t mean it can’t work, but I’ll personally be waiting for the $8.4 area break first.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.